ProbioticsÂ and Metabolic syndrome

Effects of Probiotics on Metabolic syndrome subjects

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020922

Enrollment

Registered

2019-08-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E70-E88- Metabolic disorders

Interventions

Intervention1: Probiotic capsule: Each 0 size capsule contains Registered probiotic blend of 2.5 billion cfu containing : Bacillus clausii (TBC034) 0.25 Bn.,Bifidobacterium bifidum (TBB 037) 0.5Bn.

Eligibility

Inclusion criteria

Inclusion criteria: Metabolic syndrom subjects based on hormonized createria with either gender of age between 30-65 years

Exclusion criteria

Exclusion criteria: Antibiotic use in the past 15 days or during the treatment Using probiotic during the past 1Â month Pregnant woman

Design outcomes

Primary

Measure	Time frame
To evaluate the probiotic mediated improvement in metabolic syndrome Timepoint: Testing will be done 3 months after the supplements (90 days)	—

Secondary

Measure	Time frame
To determine the effect of probiotics on blood glucose, and assess the patient compliance to the probiotic intake. Timepoint: Monthly interval (1,2and 3rd month)	—

Countries

India

Contacts

Public ContactShailedndra Raghuwanshi

Tropilite foods Pvt.ltd. Gwalior M.P. India

shailendra.raghuwanshi@tropilite.com07723873995

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026